Heart failure (HF) is a progressive condition with a clinical picture resulting from reduced
cardiac output (CO) and/or elevated left ventricular (LV) filling pressures (LVFP). The original …

Background: Although in clinical practice heart failure (HF) patients are classified using left
ventricular ejection fraction (LVEF), this categorization is insufficient for prognosis, especially …

Heart failure with preserved ejection fraction (HFpEF) represents a highly heterogeneous
clinical syndrome affected in its development and progression by many comorbidities. The …

Despite guideline recommendations and available evidence, implementation of treatment in
heart failure (HF) is poor. The majority of patients are not prescribed drugs at target doses …

A number of societies produce heart failure (HF) management guidelines, comprising official
recommendations on the basis of recent research discoveries, but their applicability to …

Aim Echo‐derived haemodynamic classification, based on forward‐flow and left ventricular
(LV) filling pressure (LVFP) correlates, has been proposed to phenotype patients with heart …

Biomarkers, typically refer to measurable substances in the circulation, excluding genetic
markers, electrolytes, and commonly used markers for liver or kidney function. To be …

Background: Classifying patients with advanced congestive heart failure (CHF) by baseline
measures of congestion and perfusion has been used to estimate hemodynamic status and …

The hemodynamic profile of heart failure (HF) patients may be critical to their clinical
outcome, whereby congestion emerges as a particularly important aspect to define …

There is increasing interest in guiding Heart Failure (HF) therapy with Brain Natriuretic
Peptide (BNP) or N-terminal prohormone of Brain Natriuretic Peptide (NT-proBNP), with the …